NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

An absolutely reasonable belief system based on logical deduction.

When one asks oneself open ended questions like how and why, one is able to open their minds to a fuller view of logical options until eliminating possibilities one by one.

There is an absolutely logical option where NWBO and the journal are coordinating release together. Since we know so few data points, many options are available. The only data point I can possibly add is that if they needed to move on to a second journal, they would have done so a few moons ago. At the very least, they are deep into editing.

In my mind, and so far as I have seen on this board, only one possible explanation remains for the reason for the halt. Every option discussed other than a regulator calling for a halt in new screening and removal of placebo as an option after DSM evaluation of deaths in unblind fashion, has been thoroughly beaten back. I only reiterate that because when one considers that, it adds credence to your theory.

You know, after they officially locked the database, they found out the true reason for the halt themselves… add this to Linda Liau and her study as well as Askan’s not so little open label trial called Specials. How long do you think they could withhold negative information from them and their prospective patients?

A journal was ready to be published shortly after May, 19th. Anyone viewing the Mt. Sinai Memorial Lecture saw that she had the full story right up to the Statistical Analysis Plan to demonstrate success already laid out clearly. The rest writes itself. She has already written a future of GBM review article and is awaiting the first by all signs. She was ready shortly after that talk, so count forward from June and you are reasonably close one way or the other. Using these deductions, before asking why and…

You are in the ballpark.